Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial
| Image |  |
|---|---|
| Description | scientific article published on 14 October 2020 |
| Author/s |
author: Mahesh K B Parmar Axel Bex James Larkin Grant D. Stewart Eleni Frangou Steven Joniau Richard S Kaplan Ian D Davis Gregers G Hermann Joaquim Bellmunt |
| Publication date | October 14, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |